0000899243-16-034882.txt : 20161202 0000899243-16-034882.hdr.sgml : 20161202 20161202214025 ACCESSION NUMBER: 0000899243-16-034882 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161130 FILED AS OF DATE: 20161202 DATE AS OF CHANGE: 20161202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OMEROS CORP CENTRAL INDEX KEY: 0001285819 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911663741 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-676-5000 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Demopulos Gregory A MD CENTRAL INDEX KEY: 0001472160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34475 FILM NUMBER: 162032522 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-11-30 0 0001285819 OMEROS CORP OMER 0001472160 Demopulos Gregory A MD 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 1 1 0 0 Chairman, CEO & President Common Stock 2016-11-30 4 M 0 97559 0.98 A 1801381 D Common Stock 2016-11-30 4 S 0 97559 12.2129 D 1703822 D Common Stock 2016-12-01 4 M 0 106521 0.98 A 1810343 D Common Stock 2016-12-01 4 S 0 105522 11.5593 D 1704821 D Common Stock 2016-12-01 4 S 0 999 12.315 D 1703822 D Common Stock 2016-12-02 4 M 0 102040 0.98 A 1805862 D Common Stock 2016-12-02 4 S 0 102040 11.0015 D 1703822 D Common Stock 2016-12-02 4 M 0 181163 0.98 A 1884985 D Stock Option (Right to Buy) 0.98 2016-11-30 4 M 0 97559 0.00 D 2016-12-11 Common Stock 97559 514685 D Stock Option (Right to Buy) 0.98 2016-12-01 4 M 0 106521 0.00 D 2016-12-11 Common Stock 106521 408164 D Stock Option (Right to Buy) 0.98 2016-12-02 4 M 0 102040 0.00 D 2016-12-11 Common Stock 102040 306124 D Stock Option (Right to Buy) 0.98 2016-12-02 4 M 0 181163 0.00 D 2016-12-11 Common Stock 181163 0 D Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person that provides for the exercise and sale of options to purchase 612,244 shares of common stock that expire on December 11, 2016 and 100 shares of common stock that expire on April 7, 2020; the latter at a threshold price of $100.00 per share. Under the plan, the options expiring on December 11, 2016, which do not provide for an extension of the exercise period, would be exercised and sold during fixed sale periods at specified prices and numbers in each sale period. Consistent with the applicable trading rules, the reporting person has had no further control over the terms or timing of sales under the plan. A portion of the proceeds from the exercise of the options expiring on December 11, 2016, all of which are non-qualified, are being used in part to fund the reporting person's exercise of all incentive stock options that otherwise would expire on December 11, 2016. See note (7) below. This transaction was executed in multiple trades at prices ranging from $12.06 to $12.59; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. This transaction was executed in multiple trades at prices ranging from $11.27 to $12.26; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. This transaction was executed in multiple trades at prices ranging from $12.27 to $12.37; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. This transaction was executed in multiple trades at prices ranging from $10.84 to $11.30; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. The option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on March 28, 2005 and subsequent installments became exercisable on each monthly anniversary thereafter. On December 2, 2016, the reporting person exercised incentive stock options to purchase 181,163 shares of common stock, which are being retained by the reporting person. /s/ Marcia S. Kelbon, attorney in-fact on behalf of Gegory A. Demopulos 2016-12-02